HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON’S DISEASE

INTRODUCTION: Homocysteine is process-product of methionine demethylation. It has proatherogenic, prothrombotic, prooxidative, proapoptotic, osteoporotic, neurotoxic, neuroinflamatory, and neurodegenerative effects. Hyperhomocysteinemia correlates with C667T MTHFR mutation, decrease of folic acid an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahimagic, Omer C., Smajlovic, Dzevdet, Dostovic, Zikrija, Pasic, Zejneba, Kunic, Suljo, Iljazovic, Amra, Hajdarevic, Denisa Salihovic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVICENA, d.o.o., Sarajevo 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034996/
https://www.ncbi.nlm.nih.gov/pubmed/27698607
http://dx.doi.org/10.5455/msm.2016.28.303-306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034996/
https://www.ncbi.nlm.nih.gov/pubmed/27698607
http://dx.doi.org/10.5455/msm.2016.28.303-306

Ejemplares similares